Skip to main content
NAGE logo

NAGE · Niagen Bioscience, Inc. · Investor Relations

Track NAGE — free
$1.87 -0.07 (-3.74%) Play latest call Q3 2026 earnings call transcript
Market Cap
$153.64M
Shares
79.20M
Volume · Nov 19 196.29K Avg daily vol (3M) 511.23K

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Upcoming events

Date Event Type
2026-11-19 22:00 UTC Southwest IDEAS Investor Conference Conference
2026-12-09 00:00 UTC 15th Annual ROTH Deer Valley Event Event
2026-12-09 00:00 UTC Sixth Annual Longevity Summit Event
2026-12-10 00:00 UTC StoneX 15th Annual Discovery Conference 2026 Conference

Recent news

Date Headline
2026-11-16 Niagen Bioscience to Present at the Sixth Annual Longevity Summit Taking Place at the Buck Institute for Research on Aging
2026-11-12 Niagen Bioscience Expands HSA/FSA Payment Option for the Pharmaceutical-Grade Niagen™ At-Home Injection Kit through Niagen™ Plus
2026-11-09 Niagen Bioscience Announces Participation in Upcoming Investor Conferences
2026-11-04 Niagen Bioscience, Inc. Reports Third Quarter 2026 Financial Results
2026-10-22 Niagen Bioscience Launches Niagen™ Plus Liquid At-Home Injections to Support Telehealth Expansion
2026-10-20 Niagen Bioscience Makes Skincare a Permanent Tru Niagen® Category, Launching Dermatologist-Tested Niagen NanoCloud™ as a Core Tru Niagen® Product
2026-10-15 Niagen Bioscience to Report Third Quarter 2026 Financial Results on Wednesday, November 4, 2026
2026-10-08 Andrew Shao, Ph.D., Senior Vice President of Global Regulatory and Scientific Affairs at Niagen Bioscience, Honored with the 2026 Annette Dickinson Trailblazer Award by Radicle Science and Council for Responsible Nutrition (CRN)
2026-10-06 Niagen Bioscience to Present at LD Micro 20th Annual Main Event
2026-10-01 Niagen Bioscience Puts 25 Years of NAD+ Science Behind "Don't Get Old. Age Better.®” a New Campaign for its Niagen® Brand Featuring Legendary Surfer Kelly Slater
2026-09-30 Niagen Bioscience Announces Start-Up Agreement With Mass General Brigham (MGB) Investigators For First-Of-Its-Kind Healthy Aging Clinical Trial
2026-09-21 Newly Published Preclinical Study Demonstrates CD38 as a Driver of Age-Related NAD+ Decline, Older Mothers Have Lower NAD+ Levels in Placental Tissue, and NAD+ Restoration with Nicotinamide Riboside (NR) Improves Pregnancy Outcomes
2026-09-17 Niagen Bioscience Engages Veteran Pharmaceutical Executives and Biotechnology Experts to Support Drug Development Program and Strategic Business Growth
2026-09-10 Niagen Bioscience to Present at Canaccord Genuity’s Well Summit
2026-09-02 Niagen Bioscience to Present at Longevity Investors Conference
2026-08-26 Niagen Bioscience to Present at Nasdaq X LD Micro Inaugural SF Summit
2026-08-20 Niagen Bioscience Expands Tru Niagen® Retail Footprint with GNC and Sam’s Club
2026-08-12 Niagen Bioscience to Present at the 17th Annual Midwest IDEAS Investor Conference
2026-08-06 Niagen Bioscience Launches Tru Niagen on Walmart.com, Expanding Access and Diversifying Its E-commerce Marketplace Presence
2026-08-04 Niagen Bioscience, Inc. Reports Second Quarter 2026 Financial Results
2026-08-03 Niagen Bioscience Selects Global Drug Development Pioneer Evotec to Advance Preclinical Development for NB4168
2026-07-28 Niagen Bioscience Announces a Newly Published Analysis of Past Clinical Studies Demonstrating Niagen® (Patented Nicotinamide Riboside, NR) Supplementation Improved a Muscle-Specific Marker of Biological Aging
2026-07-27 Niagen Bioscience to Present at Canaccord Genuity’s 46th Annual Growth Conference
2026-07-21 Niagen Bioscience to Report Second Quarter 2026 Financial Results on Tuesday, August 4, 2026
2026-07-16 Niagen Bioscience Appoints Abhijit Kale, Ph.D., as Senior Director of Global External Research

Past events

Date Event Type
2026-11-18 Southwest IDEAS Investor Conference Conference
2026-11-12 A.G.P. Virtual Consumer Showcase Conference
2026-11-11 A.G.P. Virtual Consumer Showcase Event
2026-11-04 Niagen Bioscience Third Quarter 2026 Earnings Conference Call Earnings call
2026-10-19 LD Micro 20th Annual Main Event Event
2026-09-09 Nasdaq X LD Micro Inaugural SF Summit Conference
2026-08-27 Midwest IDEAS Investor Conference Conference
2026-08-11 Canaccord Genuity 46th Annual Growth Conference Conference
2026-08-04 Niagen Bioscience Second Quarter 2026 Earnings Conference Call Earnings call
2026-07-15 KCSA Strategic Communications Fireside Chat with Rob Fried, Chief Executive Officer, Niagen Bioscience Event
2026-06-11 East Coast IDEAS Conference Presentation Conference
2026-05-06 Niagen Bioscience First Quarter 2026 Earnings Conference Call Earnings call
2026-03-23 38th Annual ROTH Conference: Technologies Advancing Healthy Aging Panel Conference
2026-03-04 Niagen Bioscience Fourth Quarter 2025 Earnings Conference Call Earnings call
2026-01-15 2nd Annual Lytham Partners Investor Summit Event
2025-11-04 Niagen Bioscience Third Quarter 2025 Earnings Conference Call Earnings call
2025-08-12 Canaccord Genuity 45th Annual Growth Conference Conference
2025-08-06 Niagen Bioscience Second Quarter 2025 Earnings Conference Call Earnings call
2025-06-09 Oppenheimer’s 25th Annual Consumer Growth and E-Commerce Conference Conference
2025-05-07 Niagen Bioscience First Quarter 2025 Earnings Conference Call Earnings call
2025-03-04 ChromaDex Fourth Quarter 2024 Earnings Conference Call Earnings call
2024-10-31 ChromaDex Third Quarter 2024 Earnings Conference Call Earnings call
2024-08-07 ChromaDex Second Quarter 2024 Earnings Conference Call Earnings call
2024-06-11 Renmark Virtual Non-Deal Roadshow Presentation Presentation
2024-05-08 ChromaDex First Quarter 2024 Earnings Conference Call Earnings call

Source: https://investors.niagenbioscience.com/overview/default.aspx

Key facts CIK 1386570 CUSIP 171077407 13F (30d) 128 filings 116 filers Visit website Investor relations